A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study. The antibiotic, rifaximin, has enabled the global ...
A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study. The antibiotic, rifaximin, has enabled the global emergence of ...